Document Detail

Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
MedLine Citation:
PMID:  20553787     Owner:  NLM     Status:  MEDLINE    
Cytochrome P450 (CYP) 1 families including CYP1A1, 1A2 and 1B1 are well known to be deeply involved in the initiation of several cancers, due to the fact that they activate environmental pro-carcinogens to form ultimate carcinogens. Benzo[a]pyrene (BaP) is one of the major classes of prototypical pro-carcinogen. It is activated by the CYP1 family to its ultimate carcinogenic forms, mainly BaP-7,8-diol-9,10-epoxide (BPDE), and it forms adducts with DNA. This has been recognized to be a major initiation pathway for cancer. Our previous study demonstrated that chrysoeriol, which is a dietary methoxyflavonoid, selectively inhibited CYP1B1 enzymatic activity and might protect the CYP1B1 related-diseases such as breast cancer. In the present study, we further examined the effects of chrysoeriol on the other initiation pathway of cancer relating to the CYP1 family with BaP in human breast cancer MCF-7 cells. The effects of chrysoeriol on the formation of BPDE-DNA adducts were analyzed specifically using the liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. When MCF-7 cells were incubated with 2 microM BaP for 24h, three types of BPDE-dG adducts, especially (+)-trans-BPDE-dG as the dominant adduct, were detected. Co-treatment of MCF-7 cells with 10 microM chrysoeriol and BaP remarkably reduced (+)-trans-BPDE-dG formation. Chrysoeriol (1-10 microM) dose-dependently inhibited both EROD activity and the gene expressions of CYP1A1, 1B1 and 1A2 stimulated by treatment with BaP. In addition, the same amounts of chrysoeriol significantly inhibited the binding of BaP to the aryl hydrocarbon receptor (AhR), which is the key factor concerning the induction of the CYP1 families. In conclusion, our results clearly indicate that chrysoeriol inhibited the formation of BPDE-DNA adducts via regulation of the AhR pathway stimulated by BaP. As a consequence chrysoeriol may be involved in the chemoprevention of environmental pro-carcinogens such as BaP.
Hitomi Takemura; Haruna Nagayoshi; Tomonari Matsuda; Hiroyuki Sakakibara; Maki Morita; Asako Matsui; Takeshi Ohura; Kayoko Shimoi
Related Documents :
1358437 - A new functional role for p-glycoprotein: efflux pump for benzo(alpha)pyrene in human b...
4048767 - The value and significance of life span and scheduled termination data in long-term tox...
22432467 - Characterization of breast cancer risk among female orthopedic surgeons in the united s...
3296317 - Perspectives on reproductive and developmental toxicity.
1625187 - Digestive cancer in relation to diet in spain.
23861747 - Prospective validation of candidate snps of vegf/vegfr pathway in metastatic colorectal...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-27
Journal Detail:
Title:  Toxicology     Volume:  274     ISSN:  1879-3185     ISO Abbreviation:  Toxicology     Publication Date:    2010 Jul-Aug
Date Detail:
Created Date:  2010-07-08     Completed Date:  2010-07-27     Revised Date:  2014-01-08    
Medline Journal Info:
Nlm Unique ID:  0361055     Medline TA:  Toxicology     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  42-8     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / analogs & derivatives
Aryl Hydrocarbon Hydroxylases
Benzo(a)pyrene / metabolism*,  pharmacology*
Breast Neoplasms / genetics,  metabolism*
Carcinogens / metabolism*,  pharmacology*
Carcinogens, Environmental / metabolism*,  pharmacology
Cell Line, Tumor
Cells / drug effects,  metabolism
Cytochrome P-450 CYP1A1 / genetics,  metabolism,  pharmacology
Cytochrome P-450 Enzyme System / antagonists & inhibitors,  genetics,  metabolism
DNA / genetics,  metabolism,  pharmacology
DNA Adducts
DNA Damage
Deoxyguanosine / analogs & derivatives
Gene Expression / drug effects
Receptors, Aryl Hydrocarbon / antagonists & inhibitors,  genetics,  metabolism
Reg. No./Substance:
0/Carcinogens; 0/Carcinogens, Environmental; 0/DNA Adducts; 0/Flavones; 0/Flavonoids; 0/Receptors, Aryl Hydrocarbon; 0/benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA; 3417WMA06D/Benzo(a)pyrene; 491-71-4/chrysoeriol; 55097-80-8/7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; 62698-04-8/7,8-dihydroxy-9,10-epoxide-7,8,9,10-tetrahydrobenzo(a)pyrene-10-deoxyguanosine; 9007-49-2/DNA; 9035-51-2/Cytochrome P-450 Enzyme System; EC Hydrocarbon Hydroxylases; EC P-450 CYP1A1; EC P-450 CYP1B1; G9481N71RO/Deoxyguanosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High follicle-stimulating hormone increases aneuploidy in human oocytes matured in vitro.
Next Document:  Epidemiology of stillbirth and strategies for its prevention in Vietnam.